New French Research Could Change India’s Tobacco Control Strategy

A major shift in France’s tobacco research is prompting a fresh global conversation on harm reduction, one that could reshape how countries like India approach smoking cessation and public health policy.

What does France’s latest tobacco research reveal about risk?

A new position from the French Ministry of Health, informed by findings from ANSES, is reframing how smokeless tobacco products are understood. After analysing over 2,500 scientific studies, the conclusion is clear yet nuanced: these products are not without risk, but they are significantly less harmful than traditional cigarettes.

At the heart of this distinction lies a simple scientific fact. Smokeless tobacco products do not involve combustion. Without burning, they avoid producing the more than 7,000 toxic chemicals found in cigarette smoke, particularly aldehydes that are known to damage the respiratory system. By removing combustion, they eliminate the primary cause of smoking-related diseases.

Why does the absence of long-term data matter?

ANSES approached its findings with caution. It described the long-term risks of smokeless tobacco as “likely” rather than definitively proven, largely due to the absence of decades-long data comparable to that of cigarettes. However, the overwhelming body of evidence on the dangers of smoking creates a critical imbalance—one that strengthens the argument for considering alternatives.

What does global research say about switching from cigarettes?

Evidence from beyond France reinforces this perspective. A large-scale study in South Korea, published in the European Journal of Cardiology, found that heart disease patients who completely switched to smokeless tobacco experienced a reduction in cardiovascular risk comparable to quitting smoking altogether. Researchers linked this to the absence of tar and carbon monoxide—two major contributors to vascular damage.

Are countries shifting towards harm reduction strategies?

Across the world, several nations are quietly moving away from blanket bans and towards harm reduction—an approach that meets smokers where they are, rather than where policymakers wish them to be.

In the United Kingdom, the “Swap to Stop” programme, launched in 2023, has already encouraged around 125,000 smokers to attempt quitting cigarettes by providing smokeless alternatives alongside behavioural support.

Dr. Vera Buss of University College London noted that individuals using smokeless tobacco products are about 50% more likely to quit smoking compared to those relying on traditional nicotine-replacement therapies.

What do trends in Asia reveal about adoption and relapse?

In Japan, one of the largest markets for heated tobacco, relapse rates tell a compelling story. Only 0.5–1% of users who switch return to cigarettes, with no upward trend observed. Meanwhile, in South Korea, smokeless tobacco products accounted for 10.6% of the market by 2020, with 99.4% of users identified as current or former smokers—not new entrants.

What could this mean for India’s public health strategy?

For India, these developments arrive at a crucial moment. The country has made significant progress in tobacco control through strong warning labels and widespread awareness campaigns. Yet, tobacco-related illnesses remain a serious concern.

This evolving global evidence opens the door for a more nuanced conversation. Rather than treating all tobacco products identically, there may be scope for a differentiated, evidence-based regulatory approach—one that acknowledges varying levels of harm.

Is harm reduction the same as accepting harm?

The growing international consensus suggests otherwise. Countries including France, the United Kingdom, Japan, Germany, and the United States are increasingly distinguishing between product categories through scientific evaluation.

Harm reduction does not mean harm acceptance. It reflects a pragmatic understanding that for millions of dependent smokers, transitioning to less harmful alternatives may be a more achievable step than quitting outright.

(With inputs from ANI)